Resultados de la búsqueda 1-10 of 3307 for ai生成作文网页版,ai网上培训,ai绘画在线网页版,ai网上课程,ai大全网址等欢迎访问豌豆Ai站群搜索引擎系统官方网站:www.wd.chat

  1. SPECIAL ISSUE: AI in cardiology

    Page 1.

  2. Ensayos clínicos - Centro Pediátrico de Mayo Clinic

    Rochester, Minn. The purposes of this study are to compare the functional connectivity in adolescent patients with Postural Orthostatic Tachycardia Syndrome ( ...

  3. Ensayos clínicos - Centro Pediátrico de Mayo Clinic

    Jacksonville, Fla. The purpose of this study is to address a knowledge gap. Early diagnosis of nerve root avulsion injuries following brachial plexus trauma ...

  4. Ensayos clínicos - Centro Pediátrico de Mayo Clinic

    Selumetinib is a drug that works by blocking some enzymes that low grade glioma tumor cells need for their growth. This results in killing tumor cells. Drugs ...

  5. Ensayos clínicos - Centro Pediátrico de Mayo Clinic

    Rochester, Minn. The aim of this study is to examine the role of mast cell mediators in children with allergic disorders in a two part study. Part 1 of the ...

  6. Clínica de las mamas - Ensayos clínicos - Mayo Clinic

    The primary aim of this study is to determine if the addition of an individual polygenic risk score (PRS) in addition to the Breast Cancer Risk Assessment ...

  7. Ensayos clínicos - Centro Pediátrico de Mayo Clinic

    Rochester, Minn. The purpose of the study is: To determine the incidence of subclinical electrographic seizures and electrographic status epilepticus in ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... AI-ECG and/or NT-pro-BNP in an at-risk adult cancer survivor population. 3D Ultrasound Imaging for Breast Cancer Diagnosis. Rochester, Minn. The purpose of ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This randomized phase II trial studies how well olaparib, cediranib maleate, and standard chemotherapy work in treating patients with small cell lung cancer ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic ...